Strategic formulation study on dry powder inhalation system based on modulated molecular properties and controlled pharmacokinetics

Yakugaku Zasshi

Volumn 133, Issue 1, 2013, Pages 93-98

  Onoue, Satomi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Airway inflammation; Amorphous; Cyclosporine A; Dry powder inhaler; Solid dispersion

Indexed keywords

CYCLOSPORIN A; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG FORMULATION; DRY POWDER INHALER; GRANULOCYTE; IN VIVO STUDY; METERED DOSE INHALER; NEBULIZER; NONHUMAN; RAT; REVIEW;

EID: 84946194506     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.12-00209     Document Type: Review

References (34)

1. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J., Adv. Drug Deliv. Rev., 46, 3-26 (2001).
2. Lipinski C. A., J. Pharmacol. Toxicol. Methods, 44, 235-249 (2000).
3. Serajuddin A. T., Adv. Drug Deliv. Rev., 59, 603-616 (2007).
4. Blagden N., de Matas M., Gavan P. T., York P., Adv. Drug Deliv. Rev., 59, 617-630 (2007).
5. Pudipeddi M., Serajuddin A. T., J. Pharm. Sci., 94, 929-939 (2005).
6. Horter D., Dressman J. B., Adv. Drug Deliv. Rev., 46, 75-87 (2001).
7. Mosharraf M., Nystroäm C., Int. J. Pharm., 122, 35-47 (1995).
8. Onoue S., Inoue R., Taniguchi C., Kawabata Y., Yamashita K., Wada K., Yamauchi Y., Yamada S., Int. J. Pharm., 426, 61-66 (2012).
9. Tran P. H., Tran T. T., Lee K. H., Kim D. J., Lee B. J., Expert Opin. Drug Deliv., 7, 647-661 (2010).
10. He C. X., He Z. G., Gao J. Q., Expert Opin. Drug Deliv., 7, 445-460 (2010).
11. Loftsson T., Brewster M. E., J. Pharm. Sci., 85, 1017-1025 (1996).
12. Brewster M. E., Loftsson T., Adv. Drug Deliv. Rev., 59, 645-666 (2007).
13. Kawabata Y., Wada K., Nakatani M., Yamada S., Onoue S., Int. J. Pharm., 420, 1-10 (2011).
14. Lobenberg R., Amidon G. L., Eur. J. Pharm. Biopharm., 50, 3-12 (2000).
15. Rajewski R. A., Stella V. J., J. Pharm. Sci., 85, 1142-1169 (1996).
16. Chiou W. L., Riegelman S., J. Pharm. Sci., 60, 1281-1302 (1971).
17. Vasconcelos T., Sarmento B., Costa P., Drug Discov. Today, 12, 1068-1075 (2007).
18. Oshima T., Sonoda R., Ohkuma M., Sunada H., Chem. Pharm. Bull., 55, 1557-1562 (2007).
19. Calderon E., Lockey R. F., Bukantz S. C., Coffey R. G., Ledford D. K., J. Allergy Clin. Immunol., 89, 629-636 (1992).
20. Amidon G. L., Lennernas H., Shah V. P., Crison J. R., Pharm. Res., 12, 413-420 (1995).
21. Wu C. Y., Benet L. Z., Pharm. Res., 22, 11-23 (2005).
22. Beauchesne P. R., Chung N. S., Wasan K. M., Drug Dev. Ind. Pharm., 33, 211-220 (2007).
23. Tjia J. F., Webber I. R., Back D. J., Br. J. Clin. Pharmacol., 31, 344-346 (1991).
24. Tam J. M., McConville J. T., Williams R. O. 3rd, Johnston K. P., J. Pharm. Sci., 97, 4915-4933 (2008).
25. Italia J. L., Bhatt D. K., Bhardwaj V., Tikoo K., Kumar M. N., J. Control. Release, 119, 197-206 (2007).
26. Woo J. S., Piao M. G., Li D. X., Ryu D. S., Choi J. Y., Kim J. A., Kim J. H., Jin S. G., Kim D. D., Lyoo W. S., Yong C. S., Choi H. G., Int. J. Pharm., 345, 134-141 (2007).
27. Ubrich N., Schmidt C., Bodmeier R., Hoffman M., Maincent P., Int. J. Pharm., 288, 169-175 (2005).
28. Onoue S., Sato H., Kawabata Y., Mizumoto T., Hashimoto N., Yamada S., J. Control. Release, 138, 16-23 (2009).
29. Onoue S., Sato H., Ogawa K., Kawabata Y., Mizumoto T., Yuminoki K., Hashimoto N., Yamada S., Int. J. Pharm., 399, 94-101 (2010).
30. Alexander A. G., Barnes N. C., Kay A. B., Lancet, 339, 324-328 (1992).
31. Nizankowska E., Soja J., Pinis G., Bochenek G., Sladek K., Domagala B., Pajak A., Szczeklik A., Eur. Respir. J., 8, 1091-1099 (1995).
32. Sato H., Kawabata Y., Yuminoki K., Hashimoto N., Yamauchi Y., Ogawa K., Mizumoto T., Yamada S., Onoue S., Int. J. Pharm., 426, 302-306 (2012).
33. Ford J. L., Pharm. Acta Helv., 61, 69-88 (1986).
34. Onoue S., Sato H., Ogawa K., Kojo Y., Aoki Y., Kawabata Y., Wada K., Mizumoto T., Yamada S., Eur. J. Pharm. Biopharm., 80, 54-60 (2012).